Valuation: Bayer AG

Market Cap 55.62B 62.32B 51.18B 46.45B 88.04B 5,841B 90.22B 612B 244B 3,127B 234B 229B 9,849B P/E 2026 *
26x
P/E 2027 * 18.9x
Enterprise Value 85.4B 95.68B 78.58B 71.32B 135B 8,968B 139B 940B 375B 4,801B 359B 351B 15,122B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.74x
Free-Float
99.99%
Yield 2026 *
0.25%
Yield 2027 * 0.94%
1 day+1.87%
1 week+13.19%
Current month+11.94%
1 month+29.36%
3 months+13.67%
6 months+53.11%
Current year+52.99%
1 week 52.18
Extreme 52.18
56.62
1 month 43.08
Extreme 43.08
56.62
Current year 32.96
Extreme 32.96
56.62
1 year 26.3
Extreme 26.3
56.62
3 years 18.38
Extreme 18.378
56.62
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 69 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 A Buy

Director

1,900 0.0002%
3/18/26 A Buy

Executive/Senior Manager

13,000 0.0013%
3/18/26 A Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.87%+13.19%+117.31%+35.44% 60.88B
+4.28%+0.07%+52.75%+138.78% 1,206B
+2.13%+4.27%+51.21%+91.36% 665B
+0.68%+1.54%+33.83%+112.47% 515B
+2.77%+0.98%+49.44%+68.46% 381B
+1.38%+0.27%+72.42%+45.30% 362B
+0.29%+1.48%+30.84%+58.32% 307B
+0.98%+1.49%+9.04%+34.78% 289B
+1.04%-0.05%+45.29%+76.18% 249B
+1.46%-0.59%+42.48%+125.82% 207B
Average +1.72%+1.64%+50.46%+78.69% 424B
Weighted average by Cap. +2.29%+0.83%+47.02%+95.17%

Financials

2026 *2027 *
Net sales 45.97B 51.5B 42.3B 38.39B 72.76B 4,827B 74.57B 506B 202B 2,584B 193B 189B 8,140B 47.2B 52.88B 43.43B 39.42B 74.71B 4,957B 76.56B 520B 207B 2,654B 198B 194B 8,358B
Net income 2.12B 2.37B 1.95B 1.77B 3.35B 222B 3.43B 23.28B 9.28B 119B 8.89B 8.7B 375B 2.87B 3.22B 2.65B 2.4B 4.55B 302B 4.66B 31.65B 12.61B 162B 12.09B 11.83B 509B
Net Debt 29.78B 33.36B 27.4B 24.87B 47.13B 3,127B 48.3B 328B 131B 1,674B 125B 123B 5,272B 26.66B 29.87B 24.53B 22.27B 42.2B 2,800B 43.25B 294B 117B 1,499B 112B 110B 4,721B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,775
Date Price Change Volume
09/11/26 €56.62 +1.87% 2,613,975
06/11/26 €55.58 -1.14% 4,309,484
05/11/26 €56.22 +3.65% 4,889,400
04/11/26 €54.24 +4.63% 4,500,817
03/11/26 €51.84 +3.64% 7,668,634
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
56.62EUR
Average target price
60.11EUR
Spread / Average Target
+6.17%
  1. Stock Market
  2. Stocks
  3. BAYN Stock